Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 13Observational 3

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 468Neoplasms 316Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 208Lung Neoplasms 178Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 60Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Interventions

gadobenic acid 2gadoteridol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Central Nervous System Diseases × Clear all
NCT03750188 2020-01-23

Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

Bracco Diagnostics, Inc

Completed
125 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT03147989 2018-07-18

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Bracco Diagnostics, Inc

Completed
352 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT02291822 2016-07-19

Retrospective Study of MRI in Pediatric Patients

Bracco Diagnostics, Inc

Completed
90 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡